U.S. Markets closed

Cochlear Limited (CHEOY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
83.06+0.74 (+0.90%)
At close: 1:31PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close82.32
Bid0.00 x 0
Ask0.00 x 0
Day's Range82.87 - 84.27
52 Week Range68.00 - 94.21
Avg. Volume1,110
Market Cap10.921B
Beta (5Y Monthly)0.33
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.89 (1.04%)
Ex-Dividend DateMar 24, 2021
1y Target EstN/A
  • PR Newswire

    Cochlear announces FDA approval and FDA clearance of first-of-its-kind Remote Care capabilities for Nucleus and Baha Systems

    Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance in the last month for its Cochlear™ Remote Assist solution in the Nucleus® and Baha® Systems. The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution are the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

  • PR Newswire

    'The Incredible Hulk' Lou Ferrigno hears with a cochlear implant

    During May's Better Hearing and Speech Month, Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, is pleased to celebrate Lou Ferrigno, 69, actor, fitness expert and retired bodybuilder, receiving a cochlear implant and addressing his hearing loss. Taking the step to treat his profound sensorineural hearing loss with a cochlear implant will aid Ferrigno's desire to remain fit and healthy as he ages.

  • PR Newswire

    New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

    Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital tool by Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions.